<prompt> Please answer with one of the option in the bracket. Write reasoning in between . Write answer in between .Q:A 52-year-old male with ischemic cardiomyopathy presents to his cardiologist for worsening shortness of breath on exertion. He denies any recent episodes of chest pain and has been compliant with his medications, which include metoprolol, lisinopril, spironolactone, and furosemide. The patients vitals signs are as follows: Temperature is 98.7 deg F 37.1 deg C, blood pressure is 16378 mmHg, pulse is 92min, respirations are 14min, and oxygen saturation is 98 on room air. A repeat echocardiogram reveals a stable LVEF of 25-35. The physician decides to start hydralazine and isosorbide dinitrate. Which of the following is true regarding this medication combination?? A: Has anti-inflammatory properties to reduce the risk of coronary artery thrombosis, B: Increases the volume of blood that enters the heart to improve ventricular contraction, C: Improves symptoms but do not have an overall mortality benefit in patients with congestive heart failure, D: Decreases the volume and work placed on the left ventricle, E: Has positive effects on cardiac remodeling,  <response>: This is a multiple choice question about medications for a patient with ischemic cardiomyopathy and worsening shortness of breath. The patient has a reduced ejection fraction indicating systolic heart failure. The question asks about starting hydralazine and isosorbide dinitrate in this patient. To answer this, we need to consider the mechanisms and effects of hydralazine and isosorbide dinitrate. These are vasodilators that work by relaxing blood vessels to reduce peripheral resistance and afterload on the heart. This decreases the volume and work required by the left ventricle, improving cardiac output and symptoms in heart failure. The other options describe incorrect mechanisms or effects of these medications.D: Decreases the volume and work placed on the left ventricle 